SCHEDULE 13G/A
Statement of Beneficial Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0000080255-26-000706
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| T. Rowe Price Associates, Inc. | 5,088,495 | 4.9% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…